Hejia Eye Care Opens First Wholly-Owned Clinic in Nanshan, Shenzhen

Jul 04, 2022 09:15 CST Updated Jul 01, 09:15

TreeENT Health

Otolaryngology Specialist Medical Service Provider

"Prureye," a chain of medical services, goes public with its stock price surging 56% on the first day

On July 5, PriFly Eye Hospital, based in Chengdu and serving all of China, successfully went public on the ChiNext Board of the A-share market. On its first day of trading, the stock price rose 56% compared to the issue price, maintaining a market value of 8 billion yuan (approximately 1.1 billion USD), making it one of the rare healthcare service stocks to go public recently. Founded in 2005, PriFly Eye Hospital operates 23 hospitals and 3 eye clinics across China, adopting a multi-level chain model of provincial capital hospitals + prefecture-level city hospitals. Refractive correction procedures are currently the largest source of revenue, followed by cataract surgeries and common eye disease treatments.Diagnosis LockMessage)

TreeENT Health Once Again Receives DNV International Healthcare Quality Certification

On July 4, TreeENT Health officially announced that its Shenzhen TreeENT Clinic had successfully passed the DNV International Healthcare Quality Certification, marking a good start for TreeENT Health in expanding the domestic market and building a new development pattern. DNV provides comprehensive risk management and assessment certification services globally, and is known as an authoritative and stringent standard certification in the industry, introduced to China in 2011. In 2020, the Hangzhou TreeENT Clinic and Day Surgery Center obtained this certification. The Shenzhen branch completed the initial DNV review within 10 months of its opening and passed the DNV quality certification six months after the preliminary review. (Source: Shenzhen News Network)

Accelerating Regional Digital Health Management, WeDoctor Secures 1 Billion Yuan in State-Owned Investment

In early July, digital healthcare platform WeDoctor announced that it had secured a financing round exceeding 1 billion yuan, led by a state-owned industrial entity from Shandong Province.InvestmentFunds. In recent years, WeDoctor has rapidly expanded its digital health community business, establishing more than 50 chronic disease service centers in places like Jinan, Tai'an, and Weifang in Shandong Province, serving nearly 2 million people with chronic diseases in the Shandong region. Additionally, in the Tianjin area, it has organized and coordinated the digital upgrade of chronic disease management for grassroots medical institutions. Reports suggest that several local state-owned capital funds are planning to invest.InvestmentFormally participate in the construction of a health community. (Ryan Capital News)

C-MER Eye Care Opens Its First Wholly-Owned Clinic in Shenzhen Nanshan

On June 30, the first clinic of Hong Kong CMER Eye Care Group, "CMER Weilan Clinic," opened in Nanshan District, Shenzhen. The clinic, located near the Nanshan business district, is equipped with essential ophthalmic devices and offers services such as orthokeratology lens fitting, eye disease examinations, pre-operative evaluations for laser vision correction, and dry eye spa treatments. CMER Eye Care operates one eye hospital each in Bao'an and Futian districts of Shenzhen, forming a "specialty hospital + satellite clinic" healthcare model that facilitates tiered diagnosis and treatment of eye diseases as well as seamless two-way referral services.

C-MER Eye Care was founded in 2012 and has successively established eye care institutions in Beijing, Shanghai, Kunming, Fuzhou, and the Greater Bay Area (Hong Kong, Shenzhen, Guangzhou, Zhuhai, Huizhou). In 2021, it completed the acquisition of Aikangjian Dental, providing high-end medical services for "eye and dental care." In the future, C-MER Eye Care will continue to deepen its involvement in the medical development of the Guangdong-Hong Kong-Macao Greater Bay Area.Diagnosis LockMessage)

East China's Largest Pediatric Ophthalmology Chain "Future Vision" Secures Series B Financing

On June 27, "Future Vision," the largest children's ophthalmology chain in East China, completed its Series B financing. This round of financing was led by YuanSheng Venture Capital, with ChengShu Investment following. Future World Ophthalmology was established in 2015, integrating ophthalmology outpatient chains and eye care product research and development. It owns 9 ophthalmology clinics and 3 optometry centers. In the future, it is expected to have 30-40 directly operated stores and 50 cooperative clinics within 3-5 years. (ZhenSuoJie News)

Musculoskeletal Digital Therapeutics Service Provider "Recovery Motion" Completes Pre-A Round of Nearly 100 Million Yuan in Financing

On June 29, Rejoice Muscle Bone announced the completion of a nearly 100-million-yuan Pre-A round of financing, invested by Qiming Venture Partners and TF Capital. Rejoice Muscle Bone was founded in Shanghai in 2018, focusing on muscleRehabilitation, Innovation in medical R&D for bones and sports medicine. On one hand, it provides digital musculoskeletal therapy products and cloud services, solving the challenges of telemedicine through a "five-specialist co-management" service model; on the other hand, it has established 2 offline musculoskeletal clinics in Shanghai.RehabilitationMedical clinics achieve closed-loop management of rehabilitation treatment. (Artery Network News)

Leading Dialysis Chain "Dakang Medical" Secures 400 Million Yuan in Series E Financing

On June 29, Dachang Medical, a leading enterprise in the chain of independent hemodialysis centers, announced the completion of its RMB 400 million E-round financing, with participation from Jiangxi and Jiangsu local state-owned enterprises and central state-owned enterprises' rural revitalization funds. As the pilot unit led by the former Ministry of Health for independent hemodialysis centers, Dachang Medical has gradually expanded to 15 provinces including Jiangxi, Shandong, Yunnan, and Guizhou, operating nearly 60 independent hemodialysis centers. It achieved overall profitability in 2019, preliminarily completing the commercial practice of independent hemodialysis centers in China. (Source: Clinic Lock)

DHC DePu Medical, an auxiliary reproductive cross-border medical group, completes multi-million A+ round financing

On June 26, DHC Medical announced the completion of a multi-million yuan Series A+ financing round in Shenzhen. The investors included LOFIS, Dingxin Capital, and others. DHC Medical Group has established the DHC Reproductive Hospital in Bangkok, Thailand, which has received authoritative medical quality certifications such as JCI and NEQAS. The group has set up miscarriage prevention clinics in Shenzhen and Guiyang, providing clients with domestic and overseas assisted reproductive medical services. In the future, it will adhere to the "China-Thailand Integrated" treatment model to expand its network service market across China. (Information from Zhen Suo Jie)

First Chronic Disease Management Stock "Zhiyun Health" Listed on HKEX

On July 6, Zhiyun Health was listed on the Main Board of the Hong Kong Stock Exchange. Founded in Hangzhou, Zhejiang in 2014, Zhiyun Health is China's largest provider of digital chronic disease management solutions. It mainly offers medical products and SaaS information services to pharmacies and hospitals, while connecting pharmaceutical companies on the other end by providing them with digital marketing solutions. It also offers patients online consultation and prescription services.

Zhiyun Health covers 2,300 hospitals and 170,000 pharmacies across China, serving over 23.8 million users, with an annual service volume of 150 million people. The company is still in a loss-making state. This IPO aims to raise 570 million Hong Kong dollars, and on the first day of listing, the stock price fell by 7% at the closing. (Source: Ryan Capital)

Cardiovascular Device Supplier Koku Medical Completes Billion-Yuan Financing

On July 5, Shanghai Koku Medical, a cardiovascular medical device industrialization solutions provider, completed an A-round financing of over 100 million yuan, led jointly by PuHua Capital and Qishen Ventures. Founded in 2016, Koku Medical focuses on the field of cardiovascular medical devices, attempting to globally search for and license cutting-edge medical inspirations and technology patents, and conducts product development and industrialization in China. Koku Medical is committed to exploring a development path of either domestic substitution or rapid following. (Investment界 News)

Medical Device Provider - Yuka Health Plans to List on Nasdaq

July 1, FujianYukai HealthYUKAI Health Group Limited ("Yukai Health"), the substantial holding company of Technology Co., Ltd., submitted a prospectus to the U.S. Securities and Exchange Commission (SEC) for a planned listing on the Nasdaq Stock Market. The public offering price is expected to be between 4 and 6 U.S. dollars, with a total of 4 million shares issued.

Yukai Health has sold medical devices in Fujian Province and served as a distributor for several medical device manufacturers, including Toshiba, Radley, and GE Healthcare China. In 2016, it entered the outsourced medical device repair market, primarily providing hospitals with medical device maintenance and repair services. (IT Juzi News)

/ END /

// Source of this article:ExpoMed

❖Solemn Declaration: The content of this article is for learning and communication only,PerspectiveThis article only represents the author's position, copyright belongs to the original author. The images in this article are based on the CC0 protocol and have been authorized. If you have any questions, please contact the editor.

/Event Preview/

Welcome to discuss in the comment area

▼

▼Click "Read More", Enter the Zhen Suo Jie Mall

This article is sourced from the WeChat Official Account: TreeENT Health